Cargando…

Analysis Of Risk Factors For Nonalcoholic Fatty-Liver Disease In Hepatitis B Virus Infection: A Case–Control Study

BACKGROUND: Nonalcoholic fatty-liver disease (NAFLD) is the most common cause of chronic liver disease worldwide. Although NAFLD has been studied extensively, potential risk factors for NAFLD among chronic hepatitis B (CHB) patients and their comparison with healthy individuals have remained underst...

Descripción completa

Detalles Bibliográficos
Autores principales:	Azarkar, Ghodsiyeh, Doosti, Zahra, Osmani, Freshteh, Ziaee, Masood
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2019
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6818534/ https://www.ncbi.nlm.nih.gov/pubmed/31749640 http://dx.doi.org/10.2147/HMER.S211106

Ejemplares similares

Fitting logistic regression models to assess vitamin D deficiency with clinical parameters in chronic hepatitis B patients
por: Osmani, Freshteh, et al.
Publicado: (2021)

Clinical characteristics and risk factors for mortality in COVID-19 inpatients in Birjand, Iran: a single-center retrospective study
por: Azarkar, Ghodsiyeh, et al.
Publicado: (2021)

Role of fatty liver in coronavirus disease 2019 patients’ disease severity and hospitalization length: a case–control study
por: Ziaee, Arash, et al.
Publicado: (2021)

Prevalence of Hepatitis D Virus Infection Among Patients With Chronic Hepatitis B Attending Birjand Hepatitis Clinic (East of Iran) in 2012
por: Ziaee, Masood, et al.
Publicado: (2013)

Prevalence of Bone Density Reduction and Its Related Factors in Hemophilia Patients in South Khorasan Province in 2018
por: Ehsanbakhsh, Alireza, et al.
Publicado: (2020)

Genotyping and Mutation Pattern in the Overlapping MHR Region of HBV Isolates in Southern Khorasan, Eastern Iran
por: Ziaee, Masood, et al.
Publicado: (2016)

Ceftriaxone-associated nephrolithiasis and gallstone in adults
por: Azarkar, Ghodsiyeh, et al.
Publicado: (2018)

Hepatitis B virus infection and the risk of nonalcoholic fatty liver disease: a meta-analysis
por: Xiong, Jianping, et al.
Publicado: (2017)

Persistence of immunity to hepatitis B vaccine as infants, 17 years earlier
por: Azarkar, Zohreh, et al.
Publicado: (2018)

Assessing the Prevalence of Ectopic Cerebellar Tonsils and Accompanying Symptoms in Individuals with Various Headaches
por: Azarkar, Ghodsiyeh, et al.
Publicado: (2023)

Hepatitis B virus infection combined with nonalcoholic fatty liver disease: Interaction and prognosis
por: Liu, Lili, et al.
Publicado: (2023)

Seroprevalence and Risk Factors for Hepatitis B in an Adult Population: The First Report from Birjand, South Khorasan, Iran
por: Ziaee, Masood, et al.
Publicado: (2016)

The prevalence of HTLV-1 and its Co-Infection with HCV, HBV and HIV in Hemophilic patients
por: Ziaee, Masood, et al.
Publicado: (2015)

Hepatic Innervations and Nonalcoholic Fatty Liver Disease
por: Adori, Monika, et al.
Publicado: (2023)

The role of hepatic macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
por: Cha, Ji-Young, et al.
Publicado: (2018)

Risk factors in nonalcoholic fatty liver disease
por: Ko, Eunji, et al.
Publicado: (2023)

Performance of two educational approaches in increasing knowledge of high-school students about COVID-19 during the first wave of pandemic
por: Janbani, Zahra, et al.
Publicado: (2023)

A New Endemic of Concomitant Nonalcoholic Fatty Liver Disease and Chronic Hepatitis B
por: Hanif, Hira, et al.
Publicado: (2020)

Hepatic MIR20B promotes nonalcoholic fatty liver disease by suppressing PPARA
por: Lee, Yo Han, et al.
Publicado: (2021)

Changing trends in liver transplantation indications in Saudi Arabia: from hepatitis C virus infection to nonalcoholic fatty liver disease
por: Alqahtani, Saleh A., et al.
Publicado: (2021)

Nonalcoholic fatty liver disease: molecular mechanisms for the hepatic steatosis
por: Koo, Seung-Hoi
Publicado: (2013)

Characteristics of hepatic insulin‐sensitive nonalcoholic fatty liver disease
por: Shigiyama, Fumika, et al.
Publicado: (2017)

Metabolic and Hepatic Effects of Empagliflozin on Nonalcoholic Fatty Liver Mice
por: Niu, Shu, et al.
Publicado: (2023)

Prevalence of HIV and Hepatitis B, C, D Infections and Their Associated Risk Factors among Prisoners in Southern Khorasan Province, Iran
por: ZIAEE, Masood, et al.
Publicado: (2014)

Effects of Phlebotomy on Liver Enzymes and Histology of Patients with Nonalcoholic Fatty Liver Disease
por: Khodadoostan, Mahsa, et al.
Publicado: (2017)

The Clinical Difference in the Platelet Counts between Liver Cirrhosis with Nonalcoholic Fatty Liver Disease and Hepatitis C Virus
por: Ikarashi, Yuichi, et al.
Publicado: (2017)

Recent Epidemiology and Risk Factors of Nonalcoholic Fatty Liver Disease
por: Huh, Youn, et al.
Publicado: (2022)

Letter regarding “Risk factors in nonalcoholic fatty liver disease”
por: Pratap, Abhijit, et al.
Publicado: (2023)

Risk factors of nonalcoholic fatty liver disease in healthy women
por: Guan, Hui, et al.
Publicado: (2023)

Nonalcoholic Fatty Liver Disease in Chronic Hepatitis B and C Patients from Western Amazon
por: Nascimento, A. C. M., et al.
Publicado: (2012)

The expression of thymosin β4 in chronic hepatitis B combined nonalcoholic fatty liver disease
por: Liang, Jing, et al.
Publicado: (2016)

Similar Connotation in Chronic Hepatitis B and Nonalcoholic Fatty Liver Patients with Dampness-Heat Syndrome
por: Dai, Jianye, et al.
Publicado: (2013)

Adverse Effect of Nonalcoholic Fatty Liver Disease on the Therapeutic Response in Patients with Chronic Hepatitis B
por: Zhang, Siyu, et al.
Publicado: (2023)

Metabolic Syndrome, Nonalcoholic Fatty Liver Disease, and Chronic Hepatitis B: A Narrative Review
por: Diao, Yuting, et al.
Publicado: (2022)

Correlations of Hepatic Hemodynamics, Liver Function, and Fibrosis Markers in Nonalcoholic Fatty Liver Disease: Comparison with Chronic Hepatitis Related to Hepatitis C Virus
por: Shigefuku, Ryuta, et al.
Publicado: (2016)

Problems with the accurate reporting of COVID-19 statistics in Iran
por: Osmani, Freshteh
Publicado: (2020)

Nonalcoholic Fatty Liver Disease
por: Filipović, Branka, et al.
Publicado: (2018)

Nonalcoholic fatty liver disease
por: Bebawi, Emmanuel, et al.
Publicado: (2023)

Nonalcoholic Fatty Liver Disease: Noninvasive Methods of Diagnosing Hepatic Steatosis
por: AlShaalan, Rasha, et al.
Publicado: (2015)

Hepatic connexin 32 associates with nonalcoholic fatty liver disease severity
por: Luther, Jay, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_4egjcijgl9at4p2ok8ccm6phjb